Lehman & Derafelo Financial Resources’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,060
Closed -$559K 179
2022
Q3
$559K Sell
5,060
-75
-1% -$8.29K 0.18% 52
2022
Q2
$385K Buy
+5,135
New +$385K 0.12% 68
2021
Q3
Sell
-12,517
Closed -$973K 221
2021
Q2
$973K Buy
12,517
+1,000
+9% +$77.7K 0.27% 51
2021
Q1
$858K Buy
11,517
+1,575
+16% +$117K 0.24% 51
2020
Q4
$1.7M Sell
9,942
-239
-2% -$40.7K 0.51% 35
2020
Q3
$1.43M Sell
10,181
-261
-2% -$36.7K 0.46% 31
2020
Q2
$1.67M Sell
10,442
-1,000
-9% -$160K 0.58% 31
2020
Q1
$1.12M Sell
11,442
-3,300
-22% -$323K 0.47% 37
2019
Q4
$1.9M Hold
14,742
0.68% 31
2019
Q3
$1.11M Buy
14,742
+7,300
+98% +$550K 0.42% 41
2019
Q2
$1.12M Hold
7,442
0.46% 39
2019
Q1
$887K Hold
7,442
0.38% 42
2018
Q4
$812K Buy
+7,442
New +$812K 0.4% 38